Why inventing a vaccine for AIDS is tougher than for COVID

The four-decades long effort to create an HIV vaccine suffered a blow last week with news that Janssen Pharmaceuticals, a division of Johnson & Johnson, was discontinuing the only current late-stage clinical trial of a vaccine. Read More